Examkin

Question

Difficulty: HardPersonality Disorders

A 28-year-old woman presents to a new primary care physician to establish care. She reports feeling chronically "empty" and describes a history of intense, unstable relationships. She recently ended her engagement after a minor disagreement and subsequently engaged in reckless driving and binge eating. She states her previous psychiatrist was "completely incompetent," whereas she feels the current physician is "the only one who truly listens." Her current medication is tranylcypromine, an monoamine oxidase inhibitor (MAOI), which she takes for atypical depression. During the evaluation, she denies active suicidal ideation or intent but mentions she occasionally feels like she would be "better off dead." Which of the following are appropriate management steps for this patient? (Select all that apply)

  1. Establish a structured treatment framework with explicit boundaries regarding communication and clinic visitsAnswer
  2. Provide a referral for dialectical behavior therapy as the primary modality of treatmentAnswer
  3. C
    Initiate fluoxetine to help manage her marked mood lability and impulsive behaviors
  4. D
    Contact her former fiancé to obtain collateral information regarding the severity of her recent reckless driving
  5. E
    Formulate a diagnosis of bipolar depression and begin sertraline monotherapy to alleviate her symptoms

Answer

Establish a structured treatment framework with explicit boundaries, and provide a referral for dialectical behavior therapy.
The patient's clinical presentation—characterized by chronic feelings of emptiness, unstable and intense interpersonal relationships, impulsivity (binge eating, reckless driving), and the idealization/devaluation (splitting) of healthcare providers—is classic for borderline personality disorder (BPD). The cornerstone of managing BPD in any clinical setting involves establishing clear, consistent boundaries to prevent splitting, manage countertransference, and ensure a stable therapeutic framework. Furthermore, the most robustly evidence-based, first-line treatment for BPD is dialectical behavior therapy (DBT), which focuses on skill-building in mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness.

Step-by-Step Solution

1
Analyze the patient's clinical presentation to determine the most likely underlying personality pathology.
The patient exhibits chronic emptiness, unstable interpersonal relationships, impulsivity (reckless driving, binge eating), and splitting (idealizing the current physician while devaluing the previous one). This presentation points directly to borderline personality disorder (BPD).
Accurate recognition of the personality disorder is required to formulate an appropriate, safe management plan and anticipate behavioral challenges.
2
Identify evidence-based non-pharmacological treatments and appropriate physician-patient dynamics for the primary diagnosis.
Dialectical behavior therapy (DBT) is the first-line treatment for BPD. Additionally, strict, consistent boundaries regarding clinic visits and communication must be established to manage splitting and prevent provider burnout.
BPD is primarily managed with specialized psychotherapy and structural boundaries rather than relying on pharmacological interventions to treat the core pathology.
3
Evaluate the patient's current medication regimen against any proposed pharmacological interventions or systemic management steps.
The patient is taking tranylcypromine, an MAOI. Adding serotonergic agents (like SSRIs) is absolutely contraindicated. Breaking confidentiality is also unwarranted as she poses no acute, imminent threat to others.
Preventing adverse drug interactions, such as fatal serotonin syndrome, and maintaining ethical standards are critical steps in safe patient management.

Key Concept

The management of Borderline Personality Disorder (BPD) primarily involves dialectical behavior therapy (DBT) and establishing strict provider-patient boundaries; polypharmacy must be approached cautiously, avoiding contraindicated combinations like MAOIs and SSRIs.
Rate this question

Topics

Personality Disorders

More questions from this topic